Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform

Company Raises $145 Million in Eighteen Months to Complete Development and Early Commercialization of Breakthrough DNA Sequencing Platform SAN DIEGO, Jan. 9, 2020 -- (Healthcare Sales & Marketing Network) -- Omniome, Inc., developer of an innovative DN... Diagnostics, Venture Capital Omniome
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news